Leslie Bernhard
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
NXL Listed Among Stocks With Notable Price Movement. Nexalin Technology shares appeared in several daily market lists tracking top gainers and notable movers. The stock is currently flagged with a high beta signal, indicating it tends to move more sharply than the broader market. While specific company news was not provided, its inclusion in these lists highlights recent volatility in trading activity.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
MLSS Highlights Scalable Growth Platform for CompuFlo®. Milestone Scientific said it is building a scalable growth platform for its CompuFlo® medical business. The company aims to expand the product line and increase market reach. This announcement may support future revenue growth. The stock is trading near its 52‑week low but has support at $0.40.
Transaction History
| SBET | ▲ Buy | Grant | 24,999 | — | 7/24/2026 | View on chart |
| SBET | ▼ Sell | Open Market | 12,892 | $96K | 5/12/2026 | View on chart |
| SBET | ▲ Buy | Grant | 11,503 | $75K | 4/10/2026 | View on chart |
| SBET | ▲ Buy | Option Exercise | 1,389 | $0 | 9/30/2025 | View on chart |
| SBET | ▼ Sell | Open Market | 18,334 | $351K | 8/18/2025 | View on chart |
| SBET | ▲ Buy | Grant | 6,667 | — | 7/24/2025 | View on chart |
| SBET | ▲ Buy | Grant | 24,998 | — | 7/24/2025 | View on chart |
| SBET | ▲ Buy | Grant | 5,556 | $0 | 6/30/2025 | View on chart |
| SBET | ▲ Buy | Option Exercise | 16,667 | $0 | 3/31/2025 | View on chart |
| SBET | ▲ Buy | Option Exercise | 10,000 | $0 | 12/20/2024 | View on chart |
| SBET | ▲ Buy | Option Exercise | 16,667 | $0 | 12/20/2024 | View on chart |
| NXL | ▲ Buy | Grant | 49,838 | $0 | 9/30/2024 | View on chart |
| SBET | ▲ Buy | Option Exercise | 10,000 | $0 | 9/30/2024 | View on chart |
| SBET | ▲ Buy | Option Exercise | 10,000 | $0 | 6/30/2024 | View on chart |
| SBET | ▲ Buy | Option Exercise | 10,000 | $0 | 3/31/2024 | View on chart |
| SACH | ▼ Sell | Open Market | 2,750 | $10K | 11/22/2023 | View on chart |
| SACH | ▼ Sell | Open Market | 1,900 | $7K | 11/15/2023 | View on chart |
| SACH | ▲ Buy | Grant | 6,000 | $0 | 9/7/2023 | View on chart |
| MLSS | ▼ Sell | Open Market | 79,268 | $40K | 12/19/2022 | View on chart |
| MLSS | ▼ Sell | Open Market | 14,358 | $9K | 11/23/2022 | View on chart |
| SACH | ▼ Sell | Open Market | 1,850 | $7K | 11/11/2022 | View on chart |
| SACH | ▼ Sell | Open Market | 625 | $3K | 8/12/2022 | View on chart |
| SACH | ▼ Sell | Open Market | 1,250 | $6K | 8/12/2022 | View on chart |
| SACH | ▲ Buy | Grant | 5,000 | $0 | 7/19/2022 | View on chart |
| MLSS | ▲ Buy | Grant | 39,634 | $32K | 6/13/2022 | View on chart |
| MLSS | ▼ Sell | Open Market | 12,089 | $16K | 4/5/2022 | View on chart |
| MLSS | ▼ Sell | Open Market | 190 | $258 | 4/5/2022 | View on chart |
| MLSS | ▼ Sell | Open Market | 1,256 | $2K | 4/5/2022 | View on chart |
| MLSS | ▼ Sell | Open Market | 1,456 | $2K | 4/5/2022 | View on chart |
| SACH | ▼ Sell | Open Market | 4,264 | $24K | 12/10/2021 | View on chart |
| SACH | ▲ Buy | Grant | 5,000 | $0 | 10/13/2021 | View on chart |
| MLSS | ▼ Sell | Open Market | 2,371 | $5K | 9/17/2021 | View on chart |
| MLSS | ▼ Sell | Open Market | 5,567 | $11K | 9/17/2021 | View on chart |
| MLSS | ▼ Sell | Open Market | 17,173 | $32K | 9/16/2021 | View on chart |
| MLSS | ▼ Sell | Open Market | 9,889 | $19K | 9/16/2021 | View on chart |
| MLSS | ▼ Sell | Open Market | 1,894 | $4K | 9/15/2021 | View on chart |
| MLSS | ▼ Sell | Open Market | 5,200 | $10K | 9/15/2021 | View on chart |
| MLSS | ▼ Sell | Open Market | 2,500 | $5K | 9/15/2021 | View on chart |
| MLSS | ▼ Sell | Open Market | 406 | $788 | 9/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Sharplink drops 5% on Ethereum buying concerns
Sharplink shares fell 5% following comments from Tom Lee that the current Ethereum buying spree is nearing its end. This sentiment also weighed on Bitmine, which dropped 7%, and Strategy, which declined 5%. The move reflects market sensitivity to shifts in digital asset accumulation strategies.
Sharplink drops 5% on Ethereum buying concerns. Sharplink shares fell 5% following comments from Tom Lee that the current Ethereum buying spree is nearing its end. This sentiment also weighed on Bitmine, which dropped 7%, and Strategy, which declined 5%. The move reflects market sensitivity to shifts in digital asset accumulation strategies.